Nokia

HEALTH EDLP

13/05/22 -"15 days ago, we were intrigued by the extent of the collapse in the Health sector (ex Pharmas) even though we had been consistently pointing to the sector's ridiculously high multiples over the last ..."

PDF page sample
Pages
46
Language
English
Published on
13/05/22
Download
You may also be interested by these reports :
24/09/26
Shelly has officialised the agreement for a takeover offer from Schneider Electric at €70 per share, a slightly disappointing amount compared to our ...
22/09/26
The key takeaway from the H1 earnings is not the figures themselves (even if our scenario of strong deterioration of FCF was more than confirmed at ...
10/09/26
There is no shortage of articulated opinions about whether there will be life after AI, let alone whether there will be financial markets left if and ...
28/08/26
Telenor’s (Add ; Norway) share price halved in 2022, not only due to rising interest rates affecting the sector, but also due to investor concerns ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO